5 Dividend Powerhouses That Could Transform Your Portfolio Into a Wealth-Building Machine24/7 Wall Street • 12/13/25
Proven Income Generators: Ranking the Most Reliable Dividend Growth Stocks24/7 Wall Street • 12/12/25
This Dividend Pharma Giant Yielding 2.9% Just Got a Big Vote of Confidence24/7 Wall Street • 12/10/25
OSE Immunotherapeutics Announces Strategic Amendment to AbbVie's Partnership on ABBV-230 DevelopmentGlobeNewsWire • 12/08/25
The Pharmaceutical Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar.The Motley Fool • 12/06/25
AbbVie Inc. (ABBV) Presents at Piper Sandler 37th Annual Healthcare Conference TranscriptSeeking Alpha • 12/03/25
AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood CancersPRNewsWire • 12/02/25
AbbVie: Increased Outlook For 2025 And Expansions Merit Continued "Strong Buy" RatingSeeking Alpha • 12/01/25
3 High-Yielding Dividend Growth Stocks That Can Generate Passive Income for Your Portfolio for YearsThe Motley Fool • 11/29/25
SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada's Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical AllianceGlobeNewsWire • 11/28/25